Life4me+-ის ერთ-ერთი მთავარი მიზანია აივ, სხვა სგგი, ჰეპატიტი C და ტუბერკულოზის ახალი შემთხვევების პრევენცია.

აპლიკაცია ეხმარება აივ დადებით პირებს ექიმებთან ანონიმური კომუნიკაციის დამყარებაში. ეს ყველაფერი დაგეხმარებათ ორგანიზება გაუკეთოთ მედიკამენტების მიღების განრიგს და დააყენოთ ფარული და პერსონალიზებული შეხსენებები.

7455

Specialized clinical information about coronavirus COVID-19

The situation is rapidly evolving, and information is being constantly updated. Last updated

View FAQs about COVID-19 and people living with HIV

View FAQs
Coronavirus Innovation Map
Coronavirus disease (COVID-19): HIV and antiretrovirals
Rights in the time of COVID-19. Lessons from HIV for an effective, community-led response.
What People Living with HIV Need to Know about HIV and COVID-19
EACS & BHIVA Statement on risk of COVID-19 for people living with HIV (PLWH)
Special CROI-2020 session on COVID-19
SARS-CoV-2 /COVID-19 - Antiviral and immunomodulatory treatment considerations
Interim clinical guidance for patients suspected of/confirmed with COVID-19 in Belgium
Inpatient guidance for treatment of COVID-19 in adults and children (University of Michigan, USA)
Руководство по лечению и поддерживающей терапии пациентов с коронавирусной инфекцией COVID-19 (Италия, Ломбардия)
Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7) (Released by National Health Commission & State Administration of Traditional Chinese Medicine)
“Solidarity” clinical trial for COVID-19 treatments
Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time
PDF
Lopinavir-ritonavir is not an effective treatment for patients hospitalised with COVID-19 (Recovery)
A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence
Therapeutic options for the 2019 novel coronavirus (2019-nCoV) in Nature Reviews
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
NIH Final report confirms remdesivir benefits for COVID-19
WHO Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
Remdesivir for the Treatment of Covid-19 — Final Report
Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.
ImmunityBio, NantKwest Announce First Patient Dosed in Phase 1 Clinical Trial of Novel COVID-19 Vaccine Candidate hAd5
Use of adenovirus type-5 vectored vaccines: a cautionary tale
“Sputnik V” the first registered COVID-9 vaccine
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
BCG vaccination to Reduce the impact of COVID-19 in Australian healthcare workers following Coronavirus Exposure (BRACE) Trial
Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) to Prevent SARS-CoV-2 Infection (in USA)
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Statement from the Chief Investigators: no clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY
A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)
A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection
EATG (European Aids Treatment Group) statement on the evolving COVID-19 pandemic
The Position of Correlation-European Harm Reduction Network and EHRA on the Continuity of Harm Reduction Services During the COVID-19 Crisis
Human Rights Dimensions of COVID-19 Response
COVID-19: Sex Workers Need Immediate Financial Support and Protection
COVID19: “Staying Home” Not an Option for People Experiencing Homelessness
Coronavirus: Healthcare and human rights of people in prison

View FAQs about COVID-19 and people living with HIV

View FAQs

If you have questions or comments about HIV and COVID-19, let us know [email protected]